Scientists ’on brink of cure’ for superbug
The Independent, May 22, 2008
Scientists have developed a drug that they say could be cure for MRSA. A British research firm claims that their discovery represented a "major breakthrough" in the battle against MRSA, a superbug responsible for the deaths of more than 1,600 patients in the UK every year. The firm, Destiny Pharma, is already carrying out human trials on the drug, and hopes to make the drug available in hospitals within three years.
- EHR Spending Continues, But Jury Still Out on ROI
- Why Is Healthcare Price Transparency So Hard?
- 5 Hot Healthcare Ideas from SXSW
- Adverse Events from Insulin Prescribing 'An Epidemic'
- Payers Detail Strategies That Drive Consumer Satisfaction
- Lahey Health Reexamines the Appropriate Care Model
- 4 Marketing Tactics for Hospitals on Instagram
- Hospital CEO Turnover Hits Record High
- Care Coordination a Cost-Cutting Quality Driver
- Hospital Groups Strike Back at Hospital Rating Systems